Biblio
Export 1 results:
Author Title Type [ Year
] Filters: Author is Espay, Alberto J and First Letter Of Keyword is P [Clear All Filters]
, “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
